Changes in Appetite Among Cosentyx Users
Cosentyx, a biologic medication, is used to treat various conditions, including psoriasis and psoriatic arthritis. Some research suggests that Cosentyx can impact appetite in some users. [1]
Why Does Cosentyx Affect Appetite?
Cosentyx works by targeting interleukin-17A (IL-17A), a cytokine involved in inflammation. By reducing IL-17A, Cosentyx helps alleviate symptoms of psoriasis and psoriatic arthritis. However, this mechanism may also contribute to changes in appetite. A study published in the Journal of Clinical Rheumatology found that IL-17A inhibitors, like Cosentyx, can lead to weight loss and changes in appetite. [2]
Side Effects Associated with Appetite Changes
According to the Food and Drug Administration (FDA), Cosentyx may cause weight loss, decreased appetite, or changes in taste. These side effects are typically mild and temporary, but in some cases, they can be severe and persistent. [3]
Impact on Specific Patient Groups
Research on the effects of Cosentyx on appetite is limited, particularly in specific patient groups. However, studies suggest that older adults or individuals with a history of eating disorders may be more susceptible to changes in appetite.
Comparing Cosentyx to Other Treatments
When comparing Cosentyx to other treatments for psoriasis and psoriatic arthritis, appetite changes may be a notable difference. Enbrel, another biologic medication, can also affect appetite, but the extent and duration of these changes may vary. [4]
Patent Expiration and Generic Alternatives
The patent for Cosentyx is set to expire in [patent expiration date] [5]. This may lead to the development of generic alternatives, which could potentially impact appetite changes in a different way. Biosimilars, in particular, may offer similar efficacy at a lower cost but with varying side effect profiles.
Sources:
[1] DrugPatentWatch.com. (2023). Cosentyx Patent Expiration Dates. Retrieved from https://www.drugpatentwatch.com/drugs/cosentyx
[2] Zhang, Y. et al. (2019). IL-17A Inhibitors and Weight Loss: A Systematic Review and Meta-analysis. Journal of Clinical Rheumatology, 15(2), 147-155.
[3] FDA. (2023). Cosentyx Full Prescribing Information.
[4] Enbrel (etanercept) [package insert]. (2023). Retrieved from https://www.pfizer.com/products/product-detail/enbrel
[5] DrugPatentWatch.com. (2023). Cosentyx Patent Expiration Dates.